Clinically significant radiation necrosis following trastuzumab-deruxtecan and brain stereotactic radiosurgery: A case series in breast cancer patients
An estimated 15% of breast cancers in the United States overexpress human epidermal growth factor receptor 2 (HER2), and patients with HER2+ breast cancer have an increased risk of developing brain metastases. The recent development of HER2-targeted agents, including trastuzumab deruxtecan (T-DXd),...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-06-01
|
| Series: | Current Problems in Cancer: Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666621923000261 |